Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhuijianpan Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Affiliated TCM Hospital of Guangzhou Medical University specifically for the treatment of lumbar disc herniation (LDH). The formula is designed to address the Liver and Kidney deficiency and Blood stasis patterns often associated with chronic back pain and radiculopathy in TCM theory. It typically comprises a blend of medicinal herbs such as Dipsaci Radix, Taxilli Herba, and Eucommiae Cortex, which are traditionally used to strengthen the musculoskeletal system and promote circulation. Clinically, Zhuijianpan Decoction is employed to reduce inflammatory responses at the site of disc protrusion, alleviate pressure-induced nerve pain, and improve the functional status of patients. Research suggests its mechanism involves the downregulation of pro-inflammatory mediators like tumor necrosis factor and various interleukins, contributing to its analgesic and anti-inflammatory profile. Clinical efficacy is often measured by improvements in the Visual Analogue Scale (VAS) for pain and the Japanese Orthopaedic Association (JOA) scores for functional mobility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhuijianpan Decoction.